IL-11 acts as a target gene for Runx2/CBFβ in metastatic BC cells and as a target of miR-124 (153) as it mediates miR-124’s inhibitory effect in osteoclasts and BC-related bone metastasis in vivo (154). This evidence concerns the gene RUNX2 and breast cancer.